Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.
Studying Aplastic Anemia
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Guangzhou General Hospital of Guangzhou Military Command
- Principal Investigator
- Yang Xiao, MDGuangzhou General Hospital of Guangzhou Military Command
- Intervention
- mesenchymal stem cells(biological)
- Enrollment
- 100 enrolled
- Eligibility
- 14-50 years · All sexes
- Timeline
- 2013 – 2018
Study locations (1)
- Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, Guangdong, China
Collaborators
Guangzhou First People's Hospital · Nanfang Hospital, Southern Medical University · Southern Medical University, China · First Affiliated Hospital, Sun Yat-Sen University · Second Affiliated Hospital, Sun Yat-Sen University · Third Affiliated Hospital, Sun Yat-Sen University · Fifth Affiliated Hospital, Sun Yat-Sen University · Guangdong Provincial People's Hospital · The Second People's Hospital of GuangDong Province · First Affiliated Hospital of Jinan University · The First Affiliated Hospital of Guangzhou Medical University · Second Affiliated Hospital of Guangzhou Medical University · Peking University Shenzhen Hospital · Shenzhen Second People's Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02247973 on ClinicalTrials.govOther trials for Aplastic Anemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07461116Adverse Effects of ATG/ALG Therapy in Aplastic AnemiaInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE2NCT07400341Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AAThe First Affiliated Hospital of Soochow University
- RECRUITINGNANCT07101770A Prediction Model in Pregnant Women With Aplastic AnemiaPeking University People's Hospital
- RECRUITINGNANCT07499284A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic AnemiaThe First Affiliated Hospital of Soochow University
- RECRUITINGPHASE2NCT06752694Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic AnemiaFred Hutchinson Cancer Center
- RECRUITINGPHASE1NCT06622694CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic AnemiaInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE2NCT06517641Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic AnemiaMedical College of Wisconsin
- RECRUITINGNANCT06936930Reproductive and Mental Health of Patients With Aplastic AnemiaInstitute of Hematology & Blood Diseases Hospital, China